DARPA Puts Biotech at the Fore

The U.S. Department of Defense is solidifying its focus on the life sciences with a new division of biotechnology.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, DEPARTMENT OF DEFENSEA new division at the U.S. Defense Advanced Research Projects Agency (DARPA) will consolidate the Department of Defense’s biology projects into a Biological Technologies Office (BTO) that will expand upon work already underway at the agency. According to a press release, “DARPA is poised to give unprecedented prominence to a field of research that can no longer be considered peripheral to technology’s evolving nature.”

“Researchers should see this move as a recognition of the enormous potential of biological technologies,” Alicia Jackson, deputy director of the BTO, told ScienceInsider in an e-mail.

Research at DARPA’s Defense Sciences Office and its Microsystems Technology Office will seed the BTO, along with a new Hand Proprioception & Touch Interfaces program. The main lines of study include prosthetics, biological manufacturing, security in bioengineering, and “biochronicity”—a program that “aims to make it possible to manage the effects of time on human physiology,” according to the release. All are aimed at shoring up the nation’s defenses.

“We’ve been developing the technological building blocks, we’ve been analyzing our results, and now we’re saying publicly to the research and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies